Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) Price to Sales (2020 - 2026)

Updated

Korro Bio's (KRRO) Price to Sales stood at 81.37 in Q2 2026, up 335.7% from 18.67 a year earlier and up 138.1% from the prior quarter.

Analysis

Korro Bio (KRRO) Price to Sales (2020 - 2026) Analysis & Trends

For FY2025, Korro Bio's Price to Sales came in at 11.80, down 92.5% from FY2024.

  • Across earlier years, Price to Sales came in at 157.20 in FY2024 and 631.06 in FY2021 (-61.0%).
  • The Q2 2026 figure is the highest quarterly Price to Sales since Q4 2024.
  • Per Business Quant, the preceding three quarters came in at 34.17 (Q1 2026), 11.80 (Q4 2025) and 61.06 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Korro Bio 281.05 Mn -128.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 137.05
Jun 30, 2026 81.37
Mar 31, 2026 34.17
Dec 31, 2025 11.80
Sep 30, 2025 61.06
Jun 30, 2025 18.67
Mar 31, 2025 33.91
Dec 31, 2024 157.20
Sep 30, 2023 63.84
Jun 30, 2023 55.80
Mar 31, 2023 160.56
Mar 31, 2022 7.87
Dec 31, 2021 12.62
Sep 30, 2021 10.16
Jun 30, 2021 9.71
Mar 31, 2021 9.46
Dec 31, 2020 32.38
Sep 30, 2020 20.41
Jun 30, 2020 16.24
API Access

Korro Bio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=KRRO&period=max&api_key=YOUR_API_KEY